Ivermectin-based onchocerciasis elimination, reported in 2009–2012, for Bakoye and Falémé, Mali, supported policy-shifting from morbidity control to elimination of transmission (EOT). These foci are coendemic with lymphatic filariasis (LF). In 2007–2016 mass ivermectin plus albendazole administration was implemented. We report Ov16 (onchocerciasis) and Wb123 (LF) seroprevalence after 24–25 years of treatment to determine if onchocerciasis EOT and LF elimination as a public health problem (EPHP) have been achieved.

中文翻译：

---

马里 Bakoye 和 Falémé 疫源地盘尾丝虫病和淋巴丝虫病消除的血清学评估

2009-2012 年报告的马里 Bakoye 和 Falémé 的基于伊维菌素的盘尾丝虫病消除支持政策从发病率控制转向消除传播 (EOT)。这些病灶与淋巴丝虫病 (LF) 共同流行。2007-2016 年大规模实施伊维菌素加阿苯达唑给药。我们报告了治疗 24-25 年后 Ov16（盘尾丝虫病）和 Wb123（LF）的血清阳性率，以确定是否已经实现了盘尾丝虫病 EOT 和 LF 消除作为公共卫生问题（EPHP）。